Bacille Calmette-Guérin (BCG) revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, ...

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

The WHO recommends vaccination against 12 deadly diseases in childhood, but how long does protection last, and how do they ...

The head of Pasteur Institute of Iran (PII) announced the export of more than 700,000 doses of the BCG vaccine to the ...

The BCG vaccine protects against tuberculosis, but by inducing trained immunity it also protects against many more ...

The Food and Drug Monitoring Agency (BPOM) has authorized phase 3 clinical trials of the M72 tuberculosis (TB) vaccine in ...

Lactate, a product of scaled-up energy production, appears to play a key role in inducing trained immunity after vaccines.

A link between metabolism and epigenetics forms the basis for trained immunityThe BCG vaccine protects against tuberculosis, but by inducing trained ...

High-risk NMIBC is characterised by poor prognosis, with half of patients recurring despite effective treatment with the ...

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

Subianto emphasized tuberculosis causes approximately 100,000 deaths annually, making its prevention a government priority.